[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT1217314B - Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale - Google Patents

Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale

Info

Publication number
IT1217314B
IT1217314B IT19434/87A IT1943487A IT1217314B IT 1217314 B IT1217314 B IT 1217314B IT 19434/87 A IT19434/87 A IT 19434/87A IT 1943487 A IT1943487 A IT 1943487A IT 1217314 B IT1217314 B IT 1217314B
Authority
IT
Italy
Prior art keywords
vivo
corporal
response
enhancing
adjuvant activity
Prior art date
Application number
IT19434/87A
Other languages
English (en)
Other versions
IT8719434A0 (it
Inventor
Nencioni Luciano
Antoni Guiod
Boraschi Diana
Tagliabue Aldo
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo Spa filed Critical Sclavo Spa
Priority to IT19434/87A priority Critical patent/IT1217314B/it
Publication of IT8719434A0 publication Critical patent/IT8719434A0/it
Priority to US07/156,301 priority patent/US5206014A/en
Priority to EP88830056A priority patent/EP0293333B1/en
Priority to AT88830056T priority patent/ATE95422T1/de
Priority to DE88830056T priority patent/DE3884672T2/de
Priority to ES88830056T priority patent/ES2059562T3/es
Priority to JP63036513A priority patent/JPS63301829A/ja
Application granted granted Critical
Publication of IT1217314B publication Critical patent/IT1217314B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/545IL-1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT19434/87A 1987-02-20 1987-02-20 Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale IT1217314B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT19434/87A IT1217314B (it) 1987-02-20 1987-02-20 Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
US07/156,301 US5206014A (en) 1987-02-20 1988-02-12 Synthetic nonapeptide for use as an adjuvant
EP88830056A EP0293333B1 (en) 1987-02-20 1988-02-16 A synthetic nonapeptide of use as an adjuvant
AT88830056T ATE95422T1 (de) 1987-02-20 1988-02-16 Ein synthetisches nonapeptid zur verwendung als adjuvant.
DE88830056T DE3884672T2 (de) 1987-02-20 1988-02-16 Ein synthetisches Nonapeptid zur Verwendung als Adjuvant.
ES88830056T ES2059562T3 (es) 1987-02-20 1988-02-16 Un nonapeptido sintetico de uso como adyuvante.
JP63036513A JPS63301829A (ja) 1987-02-20 1988-02-20 合成ノナペプチドの補助薬としての使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19434/87A IT1217314B (it) 1987-02-20 1987-02-20 Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale

Publications (2)

Publication Number Publication Date
IT8719434A0 IT8719434A0 (it) 1987-02-20
IT1217314B true IT1217314B (it) 1990-03-22

Family

ID=11157912

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19434/87A IT1217314B (it) 1987-02-20 1987-02-20 Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale

Country Status (7)

Country Link
US (1) US5206014A (it)
EP (1) EP0293333B1 (it)
JP (1) JPS63301829A (it)
AT (1) ATE95422T1 (it)
DE (1) DE3884672T2 (it)
ES (1) ES2059562T3 (it)
IT (1) IT1217314B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432402B1 (en) 1989-05-25 2002-08-13 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
DE69032855T2 (de) * 1989-05-25 1999-08-12 Sloan-Kettering Institute for Cancer Research, New York, N.Y. Antiidiotypischer antikörper, der eine immunantwort gegen ein glykosphingolipid induziert und seine verwendung
IT1262898B (it) * 1992-03-23 1996-07-22 Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk
US6270758B1 (en) 1998-10-08 2001-08-07 Duke University Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
WO2001039803A2 (en) * 1999-12-03 2001-06-07 Celltech Chiroscience Ltd. Interleukin-1 muteins useful as vaccine adjuvants

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283328A (en) * 1979-10-01 1981-08-11 Research Corporation Preparation of dehydropeptides
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
JPS57197223A (en) * 1981-05-27 1982-12-03 Eisai Co Ltd Immunoenhancing agent containing ricin b chain
DE3224379A1 (de) * 1982-06-30 1984-01-12 Hoechst Ag, 6230 Frankfurt Nonapeptid mit immunstimulierender wirkung, verfahren zu dessen herstellung und dessen verwendung
DE3230151A1 (de) * 1982-08-13 1984-02-16 Hoechst Ag, 6230 Frankfurt Neues polypeptid mit wirkung auf das immunsystem, verfahren zu seiner isolierung und reinigung, seine verwendung, dieses enthaltende mittel sowie seine spaltprodukte, deren verwendung und diese enthaltende mittel
US4845079A (en) * 1985-01-23 1989-07-04 Luly Jay R Peptidylaminodiols
IT1188550B (it) * 1986-02-07 1988-01-14 Sclavo Spa Peptide sintetico ad attivita' interleukina 1 umana

Also Published As

Publication number Publication date
EP0293333B1 (en) 1993-10-06
IT8719434A0 (it) 1987-02-20
ES2059562T3 (es) 1994-11-16
US5206014A (en) 1993-04-27
EP0293333A3 (en) 1990-09-19
ATE95422T1 (de) 1993-10-15
DE3884672T2 (de) 1994-04-28
EP0293333A2 (en) 1988-11-30
JPS63301829A (ja) 1988-12-08
DE3884672D1 (de) 1993-11-11

Similar Documents

Publication Publication Date Title
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
CA2169764A1 (en) Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
IT8722481A0 (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
EA199900751A1 (ru) Фармацевтическая композиция, содержащая лиофилизированные липосомы, включающие инкапсулированный активный ингредиент, практически нерастворимый в воде, и способ получения композиции
DE69327553D1 (de) E.Coli P-Fimbriae als immunogener Träger gegen GnRH
IT1217314B (it) Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
ES8800273A1 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
FI93843B (fi) Menetelmä angiogeenisen tekijän tuottamiseksi
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
DK0546036T3 (da) Vacciner
DE3751602D1 (de) Subkutane Verabreichung des humanen Choriongonadotropins.
IT1233419B (it) Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
IT8820888A0 (it) Peptidi di sintesi immunologicamente attivi per lapreparazione di vaccini antimalarici.
IT8821666A0 (it) Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso
SE8605513L (sv) Ny peptid och immunologiskt aktiva foreningar
ITFI920071A1 (it) Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk
RU93043610A (ru) Фармацевтическая композиция для усиления первичной иммуно-реакции у млекопитающих, способ усиления первичной иммуно-реакции и применение интерлейкина-4 для усиления первичной иммуно-реакции у млекопитающих, набор лекарственных средств
ATE88640T1 (de) Verwendung des tumor-nekrose-faktors als adjuvans der immunantwort.
IT8922409A0 (it) Peptidi sintetici e loro uso come carriers universali per la preparazione di coniugati immunogenici adatti per lo sviluppo di vaccini sintetici
IT8919110A0 (it) Peptidi sintetici e loro uso come carriers universali per la preparazione di coniugati immunogenici adatti per lo sviluppo di vaccini sintetici.